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Aims The aim of the study was to present a single-centre experience of pacemaker and implantable cardioverter deﬁbril-
lator (ICD) lead extraction using different methods, mainly laser-assisted extraction.
Methods
and results
Data from 1032 leads and 647 procedures were gathered. A step-by-step approach using different techniques while
performing an ongoing risk–beneﬁt analysis was used. The most common indications were local infection, systemic
infection, non-functional lead, elective lead replacement, and J-wire fracture. Mean implantation time for all leads was
69 months and for laser-extracted leads 91 months. Laser technique was used to extract 60% of the leads, 29% were
manually extracted, 6% extracted with mechanical tools, 4% were surgically removed, and 0.6% extracted by a
femoral approach. Failure rate was 0.7%, and major complication rate was 0.9%. No extraction-related mortality
occurred. Median time for laser extraction was 2 min. Long implantation time was not a risk factor for failure or
for complication.
Conclusion Pacing and ICD leads can safely, successfully, and effectively be extracted. Leads can often be extracted by a superior
transvenous approach; however, open-chest and femoral extractions are still required. Laser-assisted lead extraction
proved to be a useful technique to extract leads that could not be removed by manual traction. The results indicate
that the paradigm of abandoning redundant leads, instead of removing them, may have to be reconsidered.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
After implantation, transvenous device leads usually undergo ﬁbro-
tic encapsulation by activation of different cellular and humoral
mechanisms.
1 The ensuing ﬁbrotic lead adhesions tend to increase
over time. For reasons partially unknown, the inter-patient variabil-
ity is considerable. Young patients, however, usually develop ﬁbro-
tic adhesions earlier than elderly. On the contrary, systemic lead
infection seems to counteract or dissolve ﬁbrotic adherences.
Due to ﬁbrotic encapsulation, early attempts at lead extraction
were found to be difﬁcult and associated with high risks. Sub-
sequently, the paradigm of abandoning redundant leads was estab-
lished. In most centres, only leads associated with systemic
infection were indicated for extraction before the 1990s. During
this time period, most leads extracted were removed surgically.
Manual traction or methods such as weight and pulley or
forceps-assisted traction were often found to be both unsuccessful
and prone to complication. Despite improved lead performance,
an increasing number of device patients, better life expectancy,
more leads per patient, new indications, new types of devices, as
well as device and lead recalls strongly increased the need for
lead extraction. Subsequently, transvenous extraction methods
were developed. Telescoping mechanical sheaths and locking
stylets were introduced during the late 1980s and early 1990s.
Special tools for femoral lead extraction soon followed. The ﬁrst
laser-assisted lead extraction performed in 1994 was a major
breakthrough. Other methods such as electrocautery dissection
and revolving sheaths have later been introduced. The number
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doi:10.1093/europace/eup054of lead extractions has increased exponentially and in 2006,
approximately 10 000 patients underwent lead extraction just
with laser technique. Several studies from high volume centres
have shown that lead extraction can now be performed with
high success and low complication rates, employing various extrac-
tion methods.
2–5Long lead implantation time and lack of operator
experience have often been associated with extraction failure.
6–8
Due to the low complication rates, accurate risk analysis in the
best series is difﬁcult, but long implantation time, lack of operator
experience, lead type, female gender (patient size), and implan-
tation route have been discussed as possible risk factors.
The aim of this retrospective, consecutive, single-centre study is
to share our experience in removing pacemaker and implantable
cardioverter deﬁbrillator (ICD) leads using different extraction
techniques, during an early, evolutionary period of lead extraction.
Materials and methods
The centre
The Sahlgrenska University (SU) Hospital is a 2300-bed teaching hos-
pital; it is the national referral centre for lead extraction as well as
treating patients referred from abroad for lead extraction. Lead extrac-
tion is fully reimbursed in Sweden and has been since the start of its
clinical introduction in the early 1990s.
Patients
592 patients underwent 647 extraction procedures from Febru-
ary1990 to October 2007; 412 were male (70%). Mean patient age
was 62.8 years (range 10–95). The mean age of male patients was
62 years and of females 64.8 years. Several patients underwent more
than one extraction during the study duration, mainly due to recalled
leads. One patient underwent eight procedures for atrial lead replace-
ment (recalls, dislocations, and dysfunction). The majority of the
patients were referred from other hospitals; the remaining were pace-
maker and ICD patients from the SU hospital services. Few patients
were extracted during the early years of the study period; numbers
increased signiﬁcantly from 1994, largely coinciding with the Telectro-
nics AccuﬁxTM lead recall.
Indications
The Heart Rhythm Society’s (HRS) (NASPE 2000)
9 recommendations
were generally adhered to. The recommendations are, however, not
quite clear regarding local device infection. The recommendations
state that pocket infection should be treated as a Class II indication
if the lead can be severed in clean tissue and subsequently as a Class
I indication if the lead cannot be severed in clean tissue, which is the
typical situation, at least nowadays. The fact that the present rec-
ommendations do not clearly address leads infected close to the vas-
cular entry has created confusion. As a result, we treated most
localized infections as Class II before 2005 and subsequently many
pocket infection patients underwent one revision before undergoing
lead extraction. Due to a high recurrence rate (.90% at 2-year
follow-up), patients with local device infections were primarily
extracted from 2005 on, if no contraindication was present according
to the HRS recommendations. Indications were local infection 360
(35%), systemic infection (sepsis and endocarditis) 246 (24%), non-
functional lead 108 (10.5%), elective lead replacement 97 (9.4%),
J-wire lead fracture 41 (4%), ICD lead interference 25 (2.4%), insulation
defect 23 (2.1%), heart transplantation 17 (1.6%), Maze surgery
16 (1.6%), dislocation 14 (1.4%), skin erosion 14 (1.4%), lead fracture
12 (1.2%), and other indications 59 (5.7%). All patients with a Class I
indication were subjected to extraction. A low number of patients
(,15) with Class II indications were not extracted: the main reasons
being high anaesthesia risk, advanced age, long lead implantation
time, patient hesitation, or a combination of these factors. If extraction
of a non-functional lead led to an upgrade, this was classiﬁed as extrac-
tion of a non-functional lead, not upgrade, for the purpose of this
study.
Study method
Data were consecutively collected case-by-case and entered into a
computerized database and retrospectively analysed. Data on the
ﬁrst 62 patients were gathered retrospectively from patient ﬁles and
then entered into the database. Files of patients having complications
or failures were retrospectively analysed for more details.
Endpoints
Our deﬁnitions of endpoints are based on the intention-to-treat analy-
sis. ‘Clinical success’ was deﬁned as removing the entire lead or as
much of the lead as necessary to successfully treat the indicated con-
dition. Total lead removal including the lead tip was necessary for
deﬁning clinical success in Class I indication cases. Clinical success
was not achieved if a non-functional or recalled lead was not totally
removed (the intention being total removal). ‘Partial success’ was
noted when most of the lead was removed, leaving at most 4 cm of
coil and/or insulation and/or the lead tip, when the intention of the
procedure was total removal. ‘Failure’ was scored when previously
mentioned endpoints were not achieved. Crossover from one extrac-
tion technique to another was performed when necessary as part of
the step-by-step approach used. Complications were scored according
to the HRS recommendations.
9
Deﬁnitions
Manual extraction was deﬁned as the removal of a lead without using
any tool at all.
Mechanical extraction was deﬁned as the removal of a lead with the
help of mechanical sheaths with or without locking stylets or other
stylets. One lead extracted with electrosurgical dissection sheath
(EDS) technique was included in this group. Crossover from EDS to
laser was performed in ﬁve leads; these leads were included in the
laser group. Laser-assisted lead extraction was deﬁned as the
removal of leads using an excimer laser sheath, with or without a
locking stylet. Open-chest lead extraction was deﬁned as the
removal of leads through a sternotomy or thoracotomy with or
without going on bypass. Open-chest extraction was performed
either as a standalone procedure or during concomitant heart
surgery, mainly heart transplantation or Maze surgery. Primary
femoral extraction was deﬁned as the extraction of leads with a
femoral approach as the primarily chosen approach (mainly free ﬂoat-
ing leads). Secondary femoral approach was deﬁned as the removal of
leads with a femoral approach when another primary approach failed.
Laser extraction time was deﬁned as the time from the start of lasing
until the lead and laser sheath were removed from the vessel.
Extraction techniques
A step-by-step approach using different extraction techniques while
performing an ongoing risk–beneﬁt analysis, as described previously,
was routinely applied.
10,11 Subsequently, some Class II procedures
were stopped if very severe ﬁbrosis was encountered, the compli-
cation risk was signiﬁcant, and clinical success had been achieved.
An experience of over one thousand lead extractions 613Laser-assisted lead extraction, EDS extraction, mechanical extraction,
femoral extraction, and open-chest extraction were performed as
described previously.
10,11 The 14 Fr laser sheath was used for most
laser-extracted leads (49%), the 16 Fr sheath was used for 28% of
the leads, and the 12 Fr sheath was used for 23% of the leads. Laser
extractions were usually (94%) performed with a single sheath tech-
nique and with an upgraded sheath size, similar to that recommended
for an outer sheath for a certain lead diameter. Characteristics were
available for 213 leads to allow us to calculate the difference in diam-
eter between the lead and the inner diameter of the laser sheath used.
The mean diameter difference (oversizing) was 4.4 Fr (range 0.5–8.0).
One operator (C.K.) performed all transvenous extractions, usually
without an assistant. Other operators performed the minority of the
dedicated open-chest extractions, but the majority of lead extractions
during heart transplantations, Maze procedures, and cardiac surgery
for other reasons. Laser technique was used to extract 615 (60%) of
all leads, 298 (29%) were manually extracted, 70 (6.8%) with various
mechanical tools (including 1 EDS lead), 41 (4%) were surgically
removed (33 ECC), and 6 (0.6%) were primarily removed by a
femoral approach. One open-chest transatrial extraction was per-
formed with a laser sheath and was classiﬁed as a laser case. All pro-
cedures were performed in an operating room (OR) with patient
preparation and surveillance as described previously.
10,11 Acute com-
plications (perforations) were treated in the OR.
Leads
Pacing leads accounted for 974 (94%) of 1032 leads, 606 (66%) of the
pacing leads were bipolar, and 58 (5.6%) were dedicated ICD leads.
Lead tip ﬁxation was passive in 615 leads (60%) and active in 347
leads (34%). Leads implanted from 1 month on were included. Mean
implantation time for all leads was 69 months; for laser extracted
leads, the mean implantation time was 91 months. Mean implantation
time for manually extracted leads was 30 months. The maximum
number of leads removed in one patient was ﬁve. Locking stylets
were used in 59% of the leads. The mean number of leads removed
per patient was 1.74.
Table 1 shows the location, numbers, implantation time, ﬁxation
mechanism, and polarity of the leads removed.
Statistics
Categorical data were analysed with frequency tables and continuous
variables with mean, median, and standard deviation. Univariate tests
between groups were performed using Mann–Whitney U test or
Fisher’s exact test. All P-values were two-tailed, and P , 0.05 was
considered signiﬁcant. We used SPSS 15.0 for statistical analysis.
The appropriate local authority approved the electronic patient
database.
Results
Success rate
Clinical success was achieved in 97.6% (1008) of the leads, partial
success in 1.7% (17), and the extraction attempt failed in 0.7% (7)
of the leads. The mean implantation time for failed extraction
leads was 162 months. In the failure group, laser technique was
used in 5/7 leads (202 months mean implantation time), 1/7
was attempted with mechanical sheaths (118 months), and 1/7
was attempted with manual traction (7 months), the latter before
the laser technique became available. Crossover to another extrac-
tion technique was not attempted in 3/7 of these leads (two laser
and one manual) because the indication was not Class I. In
another 3/7 of the failures (all laser), extractions were abandoned
due to back bleeding from the vessel of implantation. Mechanical
extraction failed in the remaining lead (Class I). Of the failures, 4/7
leadswereClassIand3/7ClassII,noneofthelatterwereredundant
leads. The failure rates per extraction method were mechanical
1.4%, laser 0.8%, manual 0.3%, primary femoral, and surgical 0%.
All failed extraction leads were standard pacing (5/7 ventricular
and 2/7 atrial). In one of the seven failed leads, a previous unsuc-
cessful extraction attempt had been performed at another hospital.
Manual extraction was attempted in 6/17 (mean implantation
time 35 months) leads partially removed, 3/17 (77 months) leads
were associated with mechanical extraction, and 8/17 (87
months) with attempted laser extraction. Only one ICD lead
was partially removed by laser.
Slightly more failures were noted early in the study period; a
learning curve reaching statistical signiﬁcance occurred. Extraction
failure was also associated with the absence of locking stylet, young
age, and ventricular lead position. Borderline (just above 0.05) sig-
niﬁcance was noted for non-steroid leads and passive ﬁxation. Fail-
ures were not associated with implantation time (for all leads and
for laser-extracted leads), previous extraction attempts, laser use,
lead/sheath diameter difference, lead polarity, lead material
(silicon/polyurethane), patient gender, laser sheath size, or model
(SLS I/II). Active leads (127/129) were somewhat easier to success-
fully extract with manual technique than passive leads (124/137);
any difference in implantation time was not accounted for.
Complications
The major complication rate was 0.9% (four perforations, one tri-
cuspid valve insufﬁciency, and one late pleural bleeding requiring
drainage). Perforation occurred in the ventricle in 2/4 patients
and in the atrium/superior vena cava (SVC) in 2/4 patients. One
of the latter involved extraction of a dual coil ICD lead. This was
the only ICD lead related to complication. The ventricular perfor-
ations occurred at the lead tip, passive in both cases. Mean implan-
tation time for leads associated with major complications was 130
months (range 65–284). All patients with a major complication left
the hospital well and without sequel. Major complication was not
associated with implantation time, ﬁxation type, polarity, locking
stylet, insulation material, female gender, ICD lead, or class of
indication.
Minor complications occurred in nine patients. Post-operative
thrombosis occurred in 3/9 patients: all were non-pulmonary and
successfully treated. One of these patients had a retained lead frag-
ment and another had a coagulopathy. Excessive bleeding from the
vein entrance occurred in 4/9 patients; in fact, bleeding in two of
these four patients caused three of the seven lead extraction fail-
ures (failure per lead and complication per patient). Snaring tech-
niques could not remove one lead tip that was severed during
extraction and had migrated to the pulmonary vein system. One
functional left ventricular lead was ﬁbrosed to a targeted lead
and was inadvertedly dislocated. Mean implantation time for
leads associated with minor complication was 138 months (range
10–317).
No extraction-related mortality occurred. One patient,
however, died in hospital after a successful and uncomplicated
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pannus formation in the right atrium. He was refractory to all anti-
biotic treatment and accepted for surgical lead removal as a very
last resort. He recovered from surgery, but later succumbed to
infection. Another patient died at a referring hospital within 30
days due to progressive heart failure. A third patient died suddenly
outside hospital after 2 months, probably due to ventricular
arrhythmia. One patient partially extracted due to local infection
developed late endocarditis possibly related to the original
infection.
Other results
Median extraction time for laser procedures was 2 min (mean 7.2,
range 1–55). Fibrosis was most commonly located at the subcu-
taneous tissue surrounding vessels; however, the densest ﬁbrosis
was found in the curve to the brachiocephalic vein. More than
one laser sheath was used in 5.7% of the laser cases, usually to
achieve more oversizing. Median time in hospital for laser-
extracted patients was 3 days.
Discussion
The various indications in our series have, with the exception of
superﬂuous leads and leads associated with local infection, been
stable over time, however, reﬂecting periodic recalls, mainly of
the Telectronics AccuﬁxTM leads. The indications for extraction in
this study are similar to those of other recently published major
series,
5,12 differing from a third major study with a clearly higher
rate of infectious indications.
3 The low implantation rates of ICD
and cardiac resynchronization therapy systems in Sweden com-
pared with many other western countries, especially the USA, are
reﬂected in the distribution of the extracted lead types. The
results of this study regarding success rate (97.6%), serious compli-
cation rate (0.9%,), and mean implantation time (5.8 years) are
similar to the results of other major series.
2–5,13–17 Bongiorni
et al.
3 mainly using mechanical sheath techniques achieved a
success rate of 98.4%, with a serious complication rate of 0.7%,
including three deaths. Mean implantation time was 5.8 years.
Epstein and co-workers
5 mainly using laser technique achieved a
success rate of 97.5%, with a serious complication rate of 0.4%,
without mortality. Mean implantation time was 5.7 years. In detail,
comparisons of the results of studies, especially retrospective,
employing different extraction techniques are, however, difﬁcult
due to varying indications, different study designs, and different
endpoints.
Implantation time was in this study, contrary to several other
studies, not associated with failure. The lack of association
between implantation time and failure (for all leads and for laser-
extracted leads) was surprising and was rechecked. The reason
for the lack of association is probably a wide range of implantation
times for the failed leads and a very low incidence of failures
(7/1032 leads). The trend was, however, strong with a mean
implantation time for all leads of 69 months compared with
162 months for failed leads.
This study also failed to show an association between implan-
tation time and the incidence of serious complications, possibly
due to the low incidence of serious complications. Extraction
from the vein of implantation (the superior approach) was found
to be safe and efﬁcient. A high proportion of the leads (29%)
could be manually extracted, probably because leads implanted
1 month or longer were included in the study. The high proportion
of manually extracted leads may also depend on the experience
gained on how much traction lead models can sustain before
breaking.
We choose to include leads that had been implanted from
1 month on, as we wanted to include a few leads that stuck in
the tricuspid valve at implantation and subsequently were referred
for extraction. This also allowed inclusion of several leads that
required laser extraction (mainly in young patients) that had
been implanted less than 1 year. Active leads were somewhat
easier to successfully extract with manual technique than passive
leads, any difference in implantation time was not accounted for.
The explanation is probably that most active ﬁxation leads are iso-
diametric, at least pacing ones.
Laser-assisted lead extraction was, in our hands, a successful,
safe, and quick technique. The median extraction and ﬂuoroscopic
times (not reported) of this procedure were relatively short and
facilitated scheduling patients. Contrary to the originally described
extraction technique employing double telescoping mechanical
sheaths and matching inner sheath size close to the lead diameter,
we found single sheath laser technique and a certain amount of
laser sheath oversizing essential for success, especially regarding
heavily ﬁbrosed leads. Initially, only 12 Fr laser sheaths were avail-
able. Subsequently, the percentage (23%) of leads extracted with
this size of sheath is skewed, and the percentage clearly decreased
over time. When performing laser extraction, we found the
...................... .................................................. ..................................................
...............................................................................................................................................................................
Table 1 Lead characteristics
Leads n 1032 Time from
implant month
Fixation method Polarity (uni/bicoil ICD)
Mean Range Active Passive Unknown Bi Uni Unknown
Atrial 517 62 1–317 264 (51%) 227 (44%) 26 (5%) 420 (81%) 76 (15%) 21 (4%)
SVC ICD 4 65 54–84 3 (75%) 1 (25%) 4 (100%)
Ventricular 451 79 1–429 77 (17%) 332 (74%) 42 (9%) 182 (40%) 231 (51%) 38 (9%)
Ventricular ICD 54 58 1–157 6 (11%) 47 (87%) 1 (2%) 40 (74%) 14 (26%)
LV 6 14 1–47 6 (100%) 4 (67%) 2 (33%)
An experience of over one thousand lead extractions 615increased sheaths stiffness associated with using a mechanical outer
sheath to be a major disadvantage and a potential risk factor for
perforation. This applies especially when freeing leads at the bra-
chiocephalic curve and when targeting tortuous leads. The major
obstacles for extraction in our hands were dense ﬁbrosis and cal-
ciﬁcation (mainly at the vascular entrance, at the brachiocephalic
curve, and in the ventricle) and tortuous lead conﬁguration. Sur-
prisingly, we found that previous extraction attempts were not
predictive of failure. Less surprisingly, leads in which locking
stylets could not be used were associated with extraction failure.
The performance of the various locking stylet models from
different manufacturers improved over the study period (better
trackability, better ability to reach the lead tip, and better locking).
The EDS extraction technique was evaluated in a limited number
of leads and was found to be less efﬁcient than the laser (crossover
to laser with subsequent success was performed in 5/6 of these
leads). A femoral or right jugular vein approach was used for free
ﬂoating leads. The vast majority of the leads with vegetations (up
to 4 cm if not very pedunculated) were successfully extracted
with transvenous laser technique. The 16 Fr laser sheath was used
in most of these cases. Open-chest techniques were used to
extract 4% of the leads; the vast majority of these leads were
extracted during otherwise indicated heart surgery.
All patients with a Class I indication for extraction were treated:
4/7 of the failed leads were Class I, 3/7 Class II, and none of the
latter were redundant leads. It should be noted that the majority
of the partial success cases involved leaving a passive lead tip
entrapped between the clavicle and the ﬁrst rib, most likely as a
result of medial subclavian punctures. From a practical standpoint,
most of the leads classiﬁed as partial extractions were clinically
successful. The minor lead parts, which were left in these patients,
have, to our knowledge, not created problems except in one case
of late endocarditis. We ﬁnd it essential in lead extraction to apply
an ongoing risk–beneﬁt analysis and to avoid forcing extraction in
cases of discretionary indications. Trying to achieve radiographic
complete success in all Class II indication cases may not be in
the patients’ best interest. A good proportion of the successfully
extracted leads were superﬂuous and the proportion of such
leads increased over the study period, reﬂecting an increasing
demand for extraction of such leads and an increasing extractor
conﬁdence. Our results extracting superﬂuous leads should,
however, not be used as a recommendation to low volume
centres to embark on extracting such leads without doing a
serious individual risk–beneﬁt analysis and being very well pre-
pared to treat complications.
The four perforations that occurred required immediate sternot-
omy in the OR; the two atrial/SVC perforations were associated
with massive bleeding and required putting the patients on bypass.
These two patients would probably not have survived transferal
to another room for treatment. The tricuspid valve had to be
replaced in one patient (on the ﬁrst post-operative day) due to
damage during extraction. The lead was found to have been fully
encapsulated into the centre of one cusp, probably as a result of
a previous infection. This condition was not diagnosed by intrao-
perative transoesophageal echocardiography prior to extraction.
Similar to several other series we found a learning curve affecting
the failure rate.
Study limitations
The lack of association with failure and complication for most of
the factors analysed should be interpreted with some caution
due to the relatively low number of failures and complications in
the study. When comparing the failure rate of the extraction
methods used in this study, the difference in implantation times
should be noted.
This retrospective study suffers from the inherent limitations of
such studies. Only patients treated and leads extracted consecu-
tively have been analysed; no systematic registration of potential
extraction patients not treated was done. Two kinds of selection
bias may therefore affect the results of this study. First, patients
may not have been referred to our centre for various reasons. Sec-
ondly, a small number of patients did not undergo extraction,
because of their high risk. Further, patients with local infection
were for part of the study period not primarily extracted but
underwent one revision before extraction. This policy, however,
probably did not improve the results. Finally, the low risk in this
study may be affected by the small number of dual coil ICD
leads extracted.
Conclusions
Pacing and ICD leads can safely, successfully, and effectively be
extracted. Leads can often be extracted by a superior transvenous
approach; open-chest and femoral extractions are, however, still
needed. Laser-assisted lead extraction proved to be a useful tech-
nique to extract leads that could not be removed by manual trac-
tion. The results indicate that the paradigm of abandoning
redundant leads, instead of removing them, may have to be
reconsidered.
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